Literature DB >> 3811134

Intravascular macrophages in lungs of pigs infected with Haemophilus pleuropneumoniae.

T A Bertram.   

Abstract

Pigs were inoculated intratracheally with a virulent or an avirulent isolate of Haemophilus pleuropneumoniae serotype 5 and sacrificed during the first 24 hours post-inoculation. Intravascular macrophages were examined by electron microscopic and morphometric techniques. Samples of lung were taken from regions with no macroscopic lesions (Zone 0), 2.5 to 3.0 cm from lesions (Zone 1), and from the immediate edge of lesions (Zone 2). Those pigs inoculated with the avirulent isolate did not develop lesions. Pigs given the virulent isolate consistently developed necrohemorrhagic lesions in the dorsolateral aspect of the caudal and middle lung lobes. Relative volumes of intravascular macrophages in Zones 1 and 2 increased with increased time post-inoculation; in pigs given the avirulent isolate, intravascular macrophage volume decreased with increased time post-inoculation. Cytoplasmic volume to nuclear volume ratios for macrophages in Zone 2 from pigs with necrohemorrhagic lesions progressively increased with increased time post-inoculation. Enlarged intravascular macrophages had large nuclei, prominent nucleoli, and abundant cytoplasm. Increased cytoplasmic volume was the result of increased numbers of lysosomes, phagosomes, rough and smooth endoplasmic reticulum, and large Golgi complexes. Pigs inoculated with the virulent bacteria had IV macrophages with large phagosomes that contained necrotic cell debris and fibrin. Macrophages with phagosomes were more frequent in the 6-, 9-, and 24-hour sample periods of pigs with lesions than in any other group. Intercellular adhesion plaques (ICAP) were present between IV macrophages and subjacent endothelial cells. ICAP's increased in length with increased time post-inoculation in Zones 1 and 2 from pigs with necrohemorrhagic lesions. In later sample periods, multiple closely associated and interlacing IV macrophages formed a discontinuous layer over endothelial cells in Zone 2 samples near necrohemorrhagic lesions. These results suggest that the intravascular macrophage population changes from immature macrophages to mature macrophages or immature epithelioid cells within 24 hours after inhalation of a virulent Haemophilus pleuropneumoniae. Furthermore, intravascular macrophages likely function to clear cellular and acellular debris from the blood in pneumonic conditions.

Entities:  

Mesh:

Year:  1986        PMID: 3811134     DOI: 10.1177/030098588602300606

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  5 in total

1.  Description of a new population of fixed macrophages in the splenic cords of pigs.

Authors:  L Carrasco; M J Bautista; J Martin de las Mulas; J C Gómez-Villamandos; A Espinosa de los Monteros; M A Sierra
Journal:  J Anat       Date:  1995-10       Impact factor: 2.610

2.  Expression of mRNA encoding interleukin (IL)-10, IL-12p35 and IL-12p40 in lungs from pigs experimentally infected with Actinobacillus pleuropneumoniae.

Authors:  W S Cho; K Jung; J Kim; Y Ha; C Chae
Journal:  Vet Res Commun       Date:  2005-02       Impact factor: 2.459

3.  Characterization of fumonisin toxicity in orally and intravenously dosed swine.

Authors:  W M Haschek; G Motelin; D K Ness; K S Harlin; W F Hall; R F Vesonder; R E Peterson; V R Beasley
Journal:  Mycopathologia       Date:  1992-02       Impact factor: 2.574

4.  Histochemical in situ identification of bovine embryonic blood cells reveals differences to the adult haematopoietic system and suggests a close relationship between haematopoietic stem cells and primordial germ cells.

Authors:  Michaela Kritzenberger; Karl-Heinz Wrobel
Journal:  Histochem Cell Biol       Date:  2004-02-24       Impact factor: 4.304

Review 5.  Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung.

Authors:  B E Lehnert
Journal:  Environ Health Perspect       Date:  1992-07       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.